Cardinal health details momentum and updated long-term value creation plans at investor day

Key announcements: raising fy25 non-gaap diluted eps guidance to $8.15 to $8.20 1 establishing preliminary fy26 non-gaap diluted eps guidance of $9.10 to $9.30 (13% growth at the mid-points)2 confirming long-term target of 12% to 14% non-gaap diluted eps cagr for fy26 to fy283 raising long-term target for pharmaceutical and specialty solutions profit to 5% to 7% normalized growth3,4 raising long-term target for other profit to ~10% normalized growth3,4,5 updating gmpd long-term target to $50m+ of profit growth per year after fy26 expecting at least $10b in total adjusted free cash flow over next three years raising baseline share repurchase plans to at least $750m per year company reiterating strategic priorities and providing updates across its businesses dublin, ohio , june 12, 2025 /prnewswire/ -- cardinal health (nyse: cah) today will host an investor day beginning at 9:00 a.m. et, where management will detail its growth strategies to maximize the company's potential for all stakeholders.
CAH Ratings Summary
CAH Quant Ranking